Tips and tricks: how Parkinson’s patients can discover their own coping strategies
PD in Practice
Author: Mariella GrazianoPublished: 11 August 2016
Prep: Cook: Serves:
Mariella Graziano, president of the Association of Physiotherapists in Parkinson’s Disease Europe, has experience of managing people with Parkinson’s across all disease stages, and one of the most useful ways to coping with the condition often lies with the patients themselves, she argues
People with Parkinson’s are capable of developing their own creative ways to overcome daily difficulties. Over the years, health professionals have observed with admiration the effectiveness of these unique, self-created strategies that sometimes work where medication occasionally fails.
Health professionals are increasingly aware of the creative and effective power of people with Parkinson’s to help maintain their independence. In 2014 the European Physiotherapy Guideline for Parkinson’s Disease (Keus et al, 2014) made a recommendation to take into account the trick that patients developed to overcome specific problems, evaluate their safety and adequacy and to improve the strategy if required (1).
In a video presented by Anke H Snijders, MD and Bastiaan R Bloem, MD, (2010) a 58-year-old man with severe freezing of gait surprised health professionals when he was able to jump on his bicycle and cycle safely along the road with astounding agility – fending off his freezing in the process. When he jumped off the bicycle, his freezing of gait would resume.
Another ingenious strategy created by a 50-year-old man with Parkinson’s was bouncing a tennis ball during ‘off’ periods. During ‘off’ periods his arms shake violently.
Then, one day a friend threw an orange at him, and to his surprise he caught it and the tremors stopped. So, he experimented and started throwing a ball in the air and catching it again and again with his shaking hand. The tremor stopped during this action, but returned whenever he stopped. After a lot of practicing, he noticed that by bouncing the ball he could get up from the chair and it helped even to walk and run better.
Don’t underestimate the value of self-management
These cases are a source of inspiration for therapists to creatively apply and teach their patients appropriate tricks according to their specific needs. Patients’ discovery of movement strategies and cues for themselves supports the present approach of physiotherapy. It is also proof that we should actively encourage our patients to contribute to their own disease management.
European Physiotherapy Guideline for Parkinson’s Disease Samyra Keus et al (2014)
‘Cycling for Freezing of Gait’, Anke H Snijders, MD and Bastiaan R Bloem, MD (2010) in The New England Journal of Medicine
Physiotherapy and Parkinson’s disease
Between 2004 and 2007 Mariella Graziano, on behalf of the European Parkinson’s Disease Association (EPDA), organised a series of physiotherapy workshops held across the world. The aim was to share the strategies invented by people with Parkinson’s – like the ones mentioned in this article – with professionals to encourage their own contribution to disease management.
To learn more tricks and tips to help with Parkinson’s symptoms visit the EPDA ‘Coping strategies’ page here.
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”